Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure

NCT04855097 is registered in ClinicalTrials.gov with Daxor Corporation as lead sponsor.

NCT NCT04855097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure
Lead sponsor
Daxor Corporation
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2022
Completion date
December 31, 2022
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure